US Stock MarketDetailed Quotes
CTCX Carmell
- 0.318
- +0.049+18.22%
Close Nov 6 16:00 ET
- 0.330
- +0.012+3.77%
Pre 08:05 ET
6.65MMarket Cap-455P/E (TTM)
0.380High0.270Low1.71MVolume0.270Open0.269Pre Close575.92KTurnover14.28%Turnover RatioLossP/E (Static)20.91MShares4.31352wk High-4.82P/B3.81MFloat Cap0.20152wk Low--Dividend TTM11.99MShs Float13.310Historical High--Div YieldTTM40.89%Amplitude0.201Historical Low0.336Avg Price1Lot Size
About Carmell Company
Carmell Corp. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. Its products include Bone Healing Accelerant and Tissue Healing Accelerant. The company was founded on November 5, 2008 and is headquartered in Pittsburgh, PA.
Company Profile
SymbolCTCX
Company NameCarmell
Listing DateSep 23, 2021
Founded2008
CEOMs. Kendra Bracken-Ferguson
MarketNASDAQ
Employees10
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address2403 Sidney Street,Suite 300
CityPittsburgh
ProvincePennsylvania
CountryUnited States of America
Zip Code15203
Phone1-412-894-8248
Company Executives
- Name
- Position
- Salary
- Kendra Bracken-Ferguson
- Chief Executive Officer
- --
- Bryan J. Cassaday
- Chief Financial Officer and Principal Accounting Officer
- 345.36K
- Rajiv Shukla
- Executive Chairman of the Board
- 1.06M
- Scott Frisch
- Independent Director
- 167.89K
- Richard A. Upton
- Independent Director
- 25.00K
- Dr. Gilles Spenlehauer
- Independent Director
- 167.89K
- Kathryn Gregory
- Independent Director
- 25.00K
- Patrick A. Sturgeon
- Independent Director
- 180.39K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
